Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients

Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients

Background: The results of Aspirin prevention of colorectal adenomas in patients with familial adenomatous polyposis (FAP) are controversial. Methods: We conducted a biomarker-based clinical study in eight FAP patients treated with enteric-coated low-dose Aspirin (100 mg daily for three months) to e...

Full description

Bibliographic Details
Main Authors: Angel Lanas, Stefania Tacconelli, Annalisa Contursi, Elena Piazuelo, Annalisa Bruno, Maurizio Ronci, Simone Marcone, Melania Dovizio, Federico Sopeña, Lorenza Falcone, Cristina Milillo, Matteo Mucci, Patrizia Ballerini, Paola Patrignani
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
platelets
colorectal adenomas
cyclooxygenases
COX acetylation
thromboxane
prostaglandin E<sub>2</sub>
Online Access:https://www.mdpi.com/2072-6694/15/9/2457

Internet

https://www.mdpi.com/2072-6694/15/9/2457

Similar Items